Table 4 Univariate association of clinical and laboratory variables with fatal events at six‐month follow up.

	Total deaths	p Value	Cardiac deaths	p Value
Men	0.68 (0.34 to 1.36)	0.27	0.75 (0.36 to 1.53)	0.75
Age >70 years	8.14 (3.35 to 19.8)	0.00001	9.01 (3.44 to 23.06)	0.00001
Active smoking	0.32 (0.10 to 1.03)	0.06	0.23 (0.05 to 0.96)	0.013
Hypertension	1.00 (0.49 to 2.03)	0.99	0.91 (0.43 to 1.92)	0.91
Family history of CAD	1.14 (0.59 to 2.29)	0.71	1.35 (0.55 to 2.84)	0.40
Hypercholesterolaemia	0.73 (0.36 to 1.49)	0.73	0.65 (0.31 to 1.40)	0.27
Diabetes mellitus	3.77 (1.86 to 7.65)	0.0002	4.57 (2.18 to 9.59)	0.0001
Previous MI	2.69 (1.34 to 5.40)	0.006	2.96 (1.41 to 6.19)	0.004
Worsening unstable angina	3.47 (1.34 to 9.02)	0.011	5.57 (1.69 to 18.4)	0.005
Angina >20 min	1.31 (0.65 to 2.82)	0.45	1.42 (0.68 to 2.95)	0.35
β blocking agents	0.65 (0.32 to 1.31)	0.23	0.62 (0.29 to 1.30)	0.20
Calcium antagonists	1.41 (0.63 to 3.14)	0.41	1.47 (0.62 to 3.46	0.38
ACE inhibitors	1.20 (0.59 to 2.44)	0.23	1.09 (0.52 to 2.31)	0.81
Basal ST changes	1.81 (0.81 to 4.03)	0.15	2.07 (0.92 to 4.68)	0.08
Troponin I >0.4 ng/ml	2.01 (0.99 to 4.06)	0.052	2.24 (1.22 to 4.11)	0.009
C reactive protein >3 mg/l	2.60 (1.07 to 6.34)	0.036	2.71 (1.32 to 5.56)	0.007
TMI on Holter monitoring	2.72 (1.36 to 5.45)	0.005	2.50 (1.20 to 5.20)	0.014

ACE, angiotensin converting enzyme; CAD, coronary artery disease; MI, myocardial infarction; TMI, transient myocardial ischaemia. Data are presented as relative risk with 95% confidence intervals.